Pharmacological targeting of TNS3 with histone deacetylase inhibitor as a therapeutic strategy in esophageal squamous cell carcinoma.

Aging (Albany NY) · 2021 · PMC8221360 · PMID 34047714

Europe PMC DOI

hedged sentence

0.0710

closest p · 1.4× alpha

0.0710

boldest claim

The sentences

borderline significancep = 0.071so close (0.05 < p ≤ 0.1)

In addition, we detected that the higher expression of TNS3 positively correlated with the clinical TNM stage (p trend = 2.79e-03, except for stage IV), and showed borderline significance with advanced histopathological grade (p = 0.071) ( Figure 3D ).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.